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Background: The anaerobic spirochetes Brachyspira hyodysenteriae and Brachyspira pilosicoli cause diarrheal diseases
in pigs. Their fastidious nature has hampered standardization of methods for antimicrobial susceptibility testing. For
monitoring of antimicrobial susceptibility wild type cutoff values are needed to define where the wild type
distribution of MICs ends and no approved cutoffs are available for Brachyspira spp. In this study antimicrobial
susceptibility data for both species (in total 906 isolates) were compiled and analyzed and wild type cut off values
for B. hyodysenteriae proposed.
Methods: The MICs of tiamulin, valnemulin, tylosin, tylvalosin, doxycycline and lincomycin were determined by
broth dilution in brain heart infusion broth supplemented with 10% fetal calf serum.
Results: The compiled MICs from the broth dilution tests of the B. hyodysenteriae type strain, B78T (ATCCW 27164T),
showed that the method yields reproducible results. In an international perspective the frequencies of isolates with
decreased antimicrobial susceptibility were low among both B. hyodysenteriae and B. pilosicoli. However, in B.
pilosicoli a constant level of 10-15% isolates with tiamulin MICs >4 μg/ml was detected between 2002 and 2010
and in B. hyodysenteriae a gradual increase in tiamulin MICs was seen between 1990 and 2003 although this
increase has ceased during the last years. The wild type cutoff values proposed for B. hyodysenteriae are: tiamulin
>0.25 μg/ml, valnemulin >0.125 μg/ml, tylosin >16 μg/ml, tylvalosin >1 μg/ml, lincomycin >1 μg/ml and
doxycycline >0.5 μg/ml.
Conclusions: The broth dilution method used in this study has over the years generated tightly grouped MIC
populations for the field isolates and reproducible results for the control strain B78T and is therefore a suitable
antimicrobial susceptibility test method for monitoring of Brachyspira spp. Here we propose wild type cutoff values
for six antimicrobial agents for B. hyodysenteriae tested by broth dilution based on MIC distributions and the current
knowledge on mechanisms of resistance in this species. There are few studies on antimicrobial resistance
mechanisms and MIC distributions in B. pilosicoli but to some extent the cutoff values proposed for B.
hyodysenteriae may be applicable also for monitoring of antimicrobial susceptibility in B. pilosicoli.
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The anaerobic spirochete Brachyspira hyodysenteriae is
the causative agent of swine dysentery [1], a major and
serious disease of pigs world-wide. Brachyspira pilosicoli
causes a milder diarrheal disease in growing pigs, por-
cine intestinal spirochetosis, which is usually nonfatal
but impairs growth rate [2].
Antimicrobial agents such as pleuromutilins, macro-
lides and lincosamides are important in the control of
infections with both B. hyodysenteriae and B. pilosicoli
in pigs. However, development of resistance to these
antimicrobial agents is an increasing threat to the treat-
ment options and there are recent reports on multi re-
sistant isolates of B. hyodysenteriae from for example
Spain and Czech Republic [3,4]. Antimicrobial suscepti-
bility tests of Brachyspira spp. are not always performed
on a routine basis because of the fastidious nature of
these anaerobes and there are no generally approved or
recommended standards available. A broth dilution
method has been evaluated [5] and is used at the Na-
tional Veterinary Institute (SVA) in Sweden for monitor-
ing of antimicrobial susceptibility in Brachyspira spp.
Minimum inhibitory concentration (MIC) quality con-
trol ranges for the type strain of B. hyodysenteriae, B78T
(ATCCW 27164T), has been established in an inter-
laboratory study for this method [6]. However no criteria
for interpretation of the results from susceptibility tests
of Brachyspira spp. have been officially established.
For monitoring of antimicrobial susceptibility any
change in the bacteria that causes decreased susceptibil-
ity is important and wild type cutoff values are needed
to define where the wild type distribution of MICs ends.
Such wild type cutoff values are not intended for guid-
ance of therapy and should not be confused with clinical
breakpoints for resistance [7]. The aims of this study
were to compile and analyze MICs of six antibiotics for
B. hyodysenteriae and B. pilosicoli isolated between 1990
and 2010 and to propose wild type cutoff values




Swedish field isolates of B. hyodysenteriae and B. pilosi-
coli, from clinical submissions to the National Veterinary
Institute, Uppsala, between 1990 and 2010 for B. hyody-
senteriae and between 2002 and 2010 for B. pilosicoli
were used. Primary isolation and species identification
was performed as previously described [8] and the iso-
lates were stored in liquid nitrogen. The antimicrobial
agents in the test panels have changed during those
years and the number of isolates tested for each anti-
microbial agent is presented in Figure 1. For B. hyody-
senteriae the results from 1990–1999 (72 isolates) havebeen published previously [5] and for B. pilosicoli the
results from 2002–2003 (93 isolates) have been pub-
lished previously [9].
Antimicrobial susceptibility tests
Thawed isolates were grown on fastidious anaerobe agar
supplemented with 10% equine blood (FAA) (National
Veterinary Institute, Uppsala, Sweden) and subcultured
twice for three days at 37°C prior to susceptibility test-
ing. The purity of all isolates was assessed by phase con-
trast microscopy. The MICs of tiamulin, valnemulin,
tylosin, tylvalosin, doxycycline and lincomycin were
determined by broth dilution in VetMIC Brachy panels
(National Veterinary Institute, Uppsala, Sweden) as
described previously [5]. The medium for the suscepti-
bility tests was brain heart infusion broth (Difco, BD,
Sparks, Maryland) supplemented with 10% fetal calf
serum. The MIC was read as the lowest concentration of
the antimicrobial agent that prevented visible growth.
Strain B78T (B. hyodysenteriae, ATCCW 27164T) was
used as control.
Results and discussion
All tests were performed with the identical broth dilu-
tion method and in 96 separate tests the MICs for the
control strain were within proposed ranges [6]. For
pleuromutilins, this method has been compared with
agar dilution [10]. Both methods gave reproducible
results, but the broth method on average yielded a one
two-fold dilution lower MICs.
When viewed from an international perspective the
frequencies of isolates with decreased susceptibility to
the tested antimicrobial agents are low among Swedish
B. hyodysenteriae and B. pilosicoli (Figure 1 and 2).
Compared to Spain and the Czech Republic where even
multi resistant isolates are found the situation in Sweden
is very favorable [3,4]. Additionally, the frequencies of
isolates with decreased susceptibility have been stable
over time for most of the antimicrobial agents. Nonethe-
less, during the period 1990–2003 a gradual increase of
isolates with elevated tiamulin MICs was detected for B.
hyodysenteriae (Figure 1). However, this increase has
ceased and the results from 2004–2010 are comparable
to the results from 2002–2003.
Tiamulin was introduced on the Swedish market in
1988 [11] and during the 1990s the use increased mark-
edly [12]. During those years the major indication for
usage of tiamulin was swine dysentery. A control pro-
gram against swine dysentery was launched in Sweden
by the Swedish Animal Health Service year 2000 and
since then the number of B. hyodysenteriae positive sam-
ples at SVA has been decreasing [13,14]. This coincides
with a decrease in use of pleuromutilins which currently
has returned to the levels of the first years on the
Figure 1 Antimicrobial susceptibility. Distribution of MIC of six antimicrobial agents for Swedish field isolates of B. hyodysenteriae. Arrows
indicate proposed wild type cutoff values.
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Figure 2 Antimicrobial susceptibility. Distribution of MIC of six antimicrobial agents for Swedish field isolates of B. pilosicoli.
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gram nucleus and multiplying herds are certified as free
from swine dysentery by going through a sampling and
observation period of six months. If B. hyodysenteriae is
detected an eradication program is conducted. When a
herd is certified as free yearly negative samplings of pigs
susceptible to swine dysentery (20–40 kg body weight)
are required to retain the certification [15]. Based on re-
mitted samples, at present less than 1% of the herds in
Sweden are diagnosed with swine dysentery and if the
number of unrecorded cases is not too large, which the
low usage of pleuromutilins contradicts, an eradication
of the disease from the whole country may be possible.
The ceased increase in elevated tiamulin MICs may be
explained by the strategy within the control program.
During eradication of B. hyodysenteriae from a herd aplan is made how to clean the stables and treat the pigs
with tiamulin allowing only treated pigs to be moved to
clean areas until the entire herd is free. This is probably
the most favorable way of antibiotic use to avoid devel-
opment of resistance, because even if a substantial
amount of tiamulin is used during sanitation of a herd it
is a single event for a limited period. In contrast, con-
tinuous treatment with antibiotics in herds with swine
dysentery over extended periods of time is the probable
explanation to the situation of resistance reported in
Spain and the Czech Republic.
There was no change in tiamulin MIC over time for B.
pilosicoli (data not shown) and in contrast to B. hyodysen-
teriae, a constant level of approximately 10-15% of clinic-
ally tiamulin resistant B. pilosicoli (MIC 8–32 μg/ml)
isolates was detected during the years 2002–2010. In this
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included but in a previous study of B. pilosicoli (n= 41)
from 1990–2001, the tiamulin MIC was 8–32 μg/ml for
9% of the isolates. No mechanism has yet been described
for pleuromutilin resistance in B. pilosicoli.
Decreased susceptibility to tylosin in B. hyodysenteriae
and B. pilosicoli is caused by mutations in the 23S ribo-
somal RNA gene which inhibit the binding of the drug
to its target [16,17]. One single mutation changes the
tylosin MIC from 4–8 μg/ml to >256 μg/ml which gen-
erates a clear bimodal distribution (Figure 1). This muta-
tion can be selected for within a few passages in vitro
and consequently a high proportion of such isolates is
found in the field. We have previously suggested that
cross-resistance occurs between tylosin and tylvalosin in
B. hyodysenteriae [18]. The MIC population of the iso-
lates tested for tylvalosin susceptibility in this study
(n = 48) showed a tendency to a trimodal distribution
with the peaks at 1, 8 and >32 μg/ml. In Table 1 the re-
lationship between the tylvalosin, tylosin and lincomycin
MICs is presented. All 11 isolates that had tylvalosin
MIC 1 μg/ml were tylosin susceptible (MIC 4–8 μg/ml)
and all 35 isolates with tylvalosin MIC >1 μg/ml had
tylosin MICs >64 μg/ml. The lincomycin MICs followed
the results for the macrolides. However two isolates with
high tylosin MICs deviated with an unusual susceptibil-
ity pattern, having high lincomycin MICs but lower tyl-
valosin MICs than the wild type population. Possibly,
different combinations of mutations in the 23S rRNA
gene could explain both the highest tylvalosin MICs and
the pattern for the two deviating isolates but this needs
to be studied further.
For B. pilosicoli all isolates with tylvalosin MIC >16 μg/ml
also had tylosin MICs >64 μg/ml but isolates with lower tyl-
valosin MICs did not follow the pattern seen for B. hyody-
senteriae. This suggests different mechanisms or different
combinations of mechanisms for the decreased tylvalosin
susceptibility between the two species.
Decreased susceptibility to doxycycline has been asso-
ciated with a mutation in the 16S rRNA gene position
1058 (E. coli numbering) for Brachyspira intermedia iso-
lated from poultry and for B. hyodysenteriae [19,20]. The
doxycycline MIC for isolates with a G1058C mutation is
1–2 μg/ml whereas the MIC for the wild type populationTable 1 Comparison between tylosin, lincomycin and
tylvalosin MICs for the 48 isolates of Brachyspira





35 >64 16->64 2->32
11 4-8 0.5-1 1
2 >128 32 0.25-0.5is 0.063-0.5 μg/ml. Among the B. hyodysenteriae and B.
pilosicoli isolates in this study 13% and 9% respectively
had a doxycycline MIC >0.5 μg/ml.
In Brachyspira spp. decreased susceptibility to tiamulin
develops in a stepwise manner for which the genetic back-
ground is only described in part. Several mutations alter-
ing the binding site at the ribosome have been found
[3,21]. The mutations are present in different combina-
tions causing different levels of increased tiamulin MIC
and there are isolates with high tiamulin MICs in which
none of the known changes can be found. This mix of
clones with different susceptibility causes a trailing end-
point in MIC distribution diagrams and difficulties to de-
fine a wild type cutoff value to separate the wild type from
isolates with acquired decreased susceptibility. For valne-
mulin the MICs follow the tiamulin MICs in most cases
but are generally a few dilution steps lower. In Figure 1
the MICs of tiamulin for B. hyodysenteriae are shown in
two diagrams, one with all 582 isolates together and one
with three subpopulations of in total 457 isolates (1990–
1997, 1998–2001 and 2002–2003). For the first subpopu-
lation, 1990–1997, the peak of the susceptible population
is at an MIC of 0.031-0.063 μg/ml but if the popula-
tion is not divided the susceptible peak appears to be
at 0.125 μg/ml. Because the mechanisms of tiamulin re-
sistance are only partly known this masked decreased sus-
ceptibility can only be detected if monitoring begins in time
when a sufficient portion of a population under selection
pressure are still of wild type.
For monitoring of resistance it is more important to
detect the low-level resistance (or decreased susceptibil-
ity) than to find the isolates with the highest MICs. The
low-level resistance could be the first step towards
higher MICs and hence all the more important to con-
trol. To monitor a gradual decrease in susceptibility such
as for tiamulin in Brachyspira spp. a wild type cutoff
value close to the edge of the susceptible wild type dis-
tribution is needed, which would be at 0.125-0.25 μg/ml.
In the Swedish Veterinary Antimicrobial Resistance
Monitoring program (SVARM) a tiamulin cutoff for re-
sistance in B. hyodysenteriae of >2 μg/ml has been used.
This cutoff is also used at the National Veterinary Insti-
tute as a clinical breakpoint for resistance. A higher clin-
ical tiamulin MIC breakpoint (> 4 μg/ml) was proposed
by Rønne and Scanzer but has been questioned and in two
publications a clinical breakpoint of >0.5 or >1 μg/ml for
tiamulin tested by broth dilution has been discussed
[22,23]. The arguments for lowering the clinical breakpoint
are based on both pharmacokinetic data and clinical experi-
ence, although such information is limited. In this study the
purpose of the wild type cutoff values are solely to monitor
any change in the bacterial population, and not for use in
interpreting the clinical outcome of treatment with a cer-
tain drug.
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of antimicrobial susceptibility in Brachyspira hyodysen-
teriae and the percentage of non-wild type isolates gen-
erated by these for the isolates included in this study
are: tiamulin >0.25 μg/ml (8%), valnemulin >0.125 μg/ml
(5%), tylosin >16 μg/ml (75%), tylvalosin >1 μg/ml (73%),
lincomycin >1 μg/ml (74%) and doxycycline >0.5 μg/ml
(13%). These percentages do not necessarily reflect clin-
ical resistance. The wild type cutoff values are also
shown as arrows in Figure 1. For B. pilosicoli there are
few studies on antimicrobial resistance mechanisms and
MIC distributions. To some extent the cutoff values pro-
posed for B. hyodysenteriae may be applicable also for
monitoring of B. pilosicoli but the MIC distributions dif-
fer slightly and the tylvalosin and lincomycin wild type
MICs seem to be higher for B. pilosicoli.
Conclusions
The antimicrobial susceptibility tests performed with the
broth dilution method used in this study have over the
years generated tightly grouped MIC populations for the
field isolates and reproducible results for the control
strain. This stable method is therefore well suited for
monitoring of susceptibility in Brachyspira spp. To aid
detection and monitoring of antimicrobial susceptibility
wild type cutoff values that define the population of bac-
teria with no acquired phenotypically detectable resist-
ance mechanism have been established for many “bug-
drug” combinations [7]. In this study we have proposed
wild type cutoff values for six antimicrobial agents for B.
hyodysenteriae tested by broth dilution based on MIC
distributions and the current knowledge on mechanisms
of resistance in this species.
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